跳至主要内容
临床试验/NL-OMON45598
NL-OMON45598已完成2 期

Electrosclerotherapy as a novel treatment option for capillary malformations: a pilot study - Electrosclerotherapy for capillary malformations

Academisch Medisch Centrum0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • - Patients with *1 completely or partially hypertrophic capillary malformation not exclusively located in the skin of the face, the skin overlying joints or in mucosal tissue
  • - Age * 18 years
  • - Fitzpatrick skin type 1-3 without evident sun tan

排除标准

  • - Pregnant or breastfeeding women
  • - Women with childbearing potential not using contraception
  • - Patients with chronic renal dysfunction of GFR <50 ml/minute
  • - Patients with chronic pulmonary dysfuction, active pulmonary infections or previous bleomycin lung toxicity
  • - Patients with ataxia teleangiectasia
  • - Patients with previous allergic reactions to bleomycin
  • - Patients who already received the maximum dose of bleomycin (400 mg or 400000 IU/m2)
  • - Patients with implanted electrical devices such as pacemakers or ICD's
  • - Patients with clinically manifested arrhythmia
  • - Patients with epilepsy
  • - Patients who are not able to return to the hospital for follow-up visits
  • - Patients who are likely not able to understand the terms and risks of the study (e.g. cognitive impairment)

研究者

相似试验

Electrosclerotherapy as a novel treatment option for... | 临床试验